pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·3h ago·1 min read
save

Midterm ballot measures spotlight abortion, transgender rights and Medicaid expansion

Oct 20, 2026·read at STAT ↗RegulatoryNeutral

Voters in the upcoming midterm elections will weigh a series of state ballot questions that address contentious health topics such as abortion access, transgender health care and the expansion of Medicaid.

The total number of health related initiatives is lower than in 2024, when a record number of abortion measures appeared after the Supreme Court ended federal protections. Fewer proposals are linked to the Make America Healthy Again agenda, which has receded.

Four states plan to vote on measures that would prohibit transgender youth from participating in school athletic programs.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The key health care ballot measures we’re watching in the midterms”

read at STAT ↗
556 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
Immunology
topics
Immunology

related stories

  • Jul 9Ipsen succeeds in migraine trials; Tarsus buys iRenix for $75M upfrontEndpoints
  • Jul 6Cancer, immune drugmakers dominate VC funding so far in 2026BioPharma Dive
  • Jul 2STAT+: Up and down the ladder: The latest comings and goingsSTAT
  • Jun 30These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.BioPharma Dive
  • Jun 30Beeline adds $126M to Bain-backed immunology pipeline from Bristol MyersEndpoints